Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BSX

Boston Scientific Corp

Oct 24 • 04:00PM ET

101.11

-1.28 -1.25 %

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO IVV SPY VUG XLV IHI VHT IVW IWD

Scroll to Statements

Index	S&P 500	P/E	54.08	EPS (ttm)	1.87	Insider Own	0.41%	Shs Outstand	1.48B	Perf Week	1.88%
Market Cap	149.82B	Forward P/E	29.22	EPS next Y	3.46	Insider Trans	-9.53%	Shs Float	1.48B	Perf Month	3.03%
Enterprise Value	161.44B	PEG	3.35	EPS next Q	0.78	Inst Own	92.46%	Short Float	1.31%	Perf Quarter	-4.47%
Income	2.79B	P/S	7.74	EPS this Y	20.69%	Inst Trans	-0.03%	Short Ratio	2.25	Perf Half Y	-0.78%
Sales	19.35B	P/B	6.68	EPS next Y	14.23%	ROA	6.37%	Short Interest	19.40M	Perf YTD	13.20%
Book/sh	15.14	P/C	233.00	EPS next 5Y	16.12%	ROE	11.71%	52W High	109.50 -7.66%	Perf Year	14.88%
Cash/sh	0.43	P/FCF	42.99	EPS past 3/5Y	21.99% -17.84%	ROIC	8.22%	52W Low	80.64 25.38%	Perf 3Y	146.85%
Dividend Est.	-	EV/EBITDA	36.72	Sales past 3/5Y	12.10% 9.30%	Gross Margin	68.99%	Volatility	2.19% 2.45%	Perf 5Y	167.70%
Dividend TTM	-	EV/Sales	8.34	EPS Y/Y TTM	54.80%	Oper. Margin	17.87%	ATR (14)	2.35	Perf 10Y	492.33%
Dividend Ex-Date	-	Quick Ratio	0.82	Sales Y/Y TTM	21.62%	Profit Margin	14.43%	RSI (14)	55.58	Recom	1.27
Dividend Gr. 3/5Y	- -	Current Ratio	1.37	EPS Q/Q	60.10%	SMA20	3.18%	Beta	0.58	Target Price	127.42
Payout	0.00%	Debt/Eq	0.54	Sales Q/Q	20.34%	SMA50	-0.00%	Rel Volume	0.79	Prev Close	102.39
Employees	53000	LT Debt/Eq	0.52	Earnings	Oct 22 BMO	SMA200	-0.60%	Avg Volume	8.64M	Price	101.11
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.09% 1.93%	Trades		Volume	6,791,399	Change	-1.25%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-03-25	Downgrade	Erste Group	Buy → Hold
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform	$125
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55

Show Previous Ratings

Oct-23-25 02:00PM	BSX Q3 Deep Dive: WATCHMAN and Electrophysiology Drive Outperformance, Guidance Raised (StockStory)
12:48PM	WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit (Zacks)
12:45PM	Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
09:45AM	Here's Why Boston Scientific (BSX) is a Strong Growth Stock (Zacks)
09:30AM	Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? (Zacks)
09:30AM	Loading…
09:30AM	Boston Scientific (BSX) Recently Broke Out Above the 50-Day Moving Average (Zacks)
09:30AM	Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors (Zacks)
09:28AM	Company News for Oct 23, 2025 (Zacks)
Oct-22-25 04:07PM	Boston Scientific Makes A Bullish Move After Sales In One Segment Skyrocket 63% (Investor's Business Daily)
03:01PM	Boston Scientific Corp (BSX) Q3 2025 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
02:00PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
01:44PM	Boston Scientific lifts FY25 outlook amid continued cardiovascular boom (Medical Device Network)
01:25PM	GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring (Zacks)
11:51AM	Boston Scientific (BSX) Stock Is Up, What You Need To Know (StockStory)
09:30AM	Boston Scientific (BSX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:23AM	Loading…
09:23AM	Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up (Zacks)
08:53AM	Boston Scientific Jumps On Third-Quarter Beat, Strong Guide (Investor's Business Daily)
08:09AM	Earnings live: Netflix stock dives, AT&T, GE Vernova, and Hilton rise as Tesla earnings loom (Yahoo Finance)
08:05AM	Boston Scientific continues to win in electrophysiology (MedTech Dive)
07:45AM	Boston Scientific (BSX) Q3 Earnings and Revenues Top Estimates (Zacks)
07:11AM	Beware The Death Cross: 3 Stocks Triggering This Spooky Signal (MarketBeat)
07:01AM	Boston Scientific's (NYSE:BSX) Q3 Sales Top Estimates (StockStory)
06:59AM	Boston Scientific Raises Outlook on Continued Cardiovascular Growth (The Wall Street Journal)
06:40AM	Boston Scientific: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Boston Scientific announces results for third quarter 2025 (PR Newswire)
05:02AM	Tesla headlines Wednesday's earnings slate (MarketWatch)
04:29AM	Stock Market Today: Dow, S&P 500 and Nasdaq eye open near record highs as Treasury yields stay below 4%; Tesla and IBM earnings on tap. (MarketWatch)
03:36AM	Tesla Earnings, Inflation Data: What to Watch Over the Rest of This Week (The Wall Street Journal)
Oct-21-25 04:35PM	Earnings live: Netflix stock falls while AT&T, GE Vernova, and Hilton rise on Q3 results (Yahoo Finance)
04:35PM	Earnings live: GM stock soars, Netflix sinks as third quarter results pour in (Yahoo Finance)
10:06AM	Loading…
10:06AM	HIMS Stock Declines Despite Launch of New Specialty in Women's Health (Zacks)
08:13AM	Earnings live: General Motors and GE raise guidance, Coca-Cola stock rises on earnings beat (Yahoo Finance)
06:33AM	Analyst Visit Confirms Growth Potential for Boston Scientific Corporation (BSX), Buy Rating Retained (Insider Monkey)
02:57AM	Inflation Data; Intel and Tesla Earnings: What to Watch This Week (The Wall Street Journal)
Oct-20-25 11:08PM	Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
04:30PM	Earnings live: Cleveland-Cliffs stock soars, Zions Bancorp rises with results from GM, Netflix on deck (Yahoo Finance)
09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
09:32AM	Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains (Zacks)
08:45AM	Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings (Zacks)
08:22AM	Earnings live: Tesla, Netflix, General Motors, Ford, and P&G to headline third quarter earnings calendar this week (Yahoo Finance)
02:36AM	Inflation Data; Intel and Tesla Earnings: What to Watch This Week (The Wall Street Journal)
Oct-19-25 07:33AM	Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week (Yahoo Finance)
Oct-17-25 02:41PM	Inflation Data, Intel and Tesla Earnings: What to Watch Next Week (The Wall Street Journal)
12:22PM	Boston Scientific acquires Nalu Medical for $533m (Medical Device Network)
09:15AM	Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics (Zacks)
09:09AM	Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now? (Zacks)
07:00AM	Boston Scientific to buy Nalu Medical for $533M (MedTech Dive)
07:00AM	Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc. (PR Newswire)
Oct-16-25 08:46AM	Will Robust Cardiovascular Performance Fuel BSX's Q3 Earnings? (Zacks)
Oct-15-25 10:00AM	Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:07AM	Can Ion Emerge as ISRG's Vehicle to Tap Ambulatory Care Growth? (Zacks)
08:05AM	Abbott CEO: Were right on time to the PFA party (MedTech Dive)
Oct-14-25 08:59AM	What Makes Boston Scientific Corporation (BSX) an Investment Choice? (Insider Monkey)
Oct-13-25 02:53PM	9 Stocks to Buy Before Their Earnings Reports (Barrons.com)
08:20AM	Is J&J's MedTech Segment Set for Another Quarter of Growth? (Zacks)
Oct-10-25 06:00PM	Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know (Zacks)
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
08:39AM	Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs (Zacks)
Oct-07-25 08:23AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Oct-06-25 10:09AM	What You Need To Know Ahead of Boston Scientific's Earnings Release (Barchart)
09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
08:04AM	BRKR Shares Climb After Securing New Orders for Its NMR Systems (Zacks)
Oct-03-25 09:40AM	Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year? (Zacks)
09:35AM	Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX) (Zacks)
08:21AM	HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests (Zacks)
06:27AM	RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT (Insider Monkey)
05:54AM	Medtronic wins CE mark for Penditure LAA exclusion device (MedTech Dive)
05:01AM	The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco (Zacks)
Oct-02-25 05:06PM	Top Research Reports for Boston Scientific, Union Pacific & Realty Income (Zacks)
07:06AM	Boston Scientific aims for market leadership in electrophysiology (MedTech Dive)
Oct-01-25 06:00PM	Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts (Zacks)
09:10AM	Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum (Zacks)
06:55AM	Boston Scientific unveils plans for new Watchman device (MedTech Dive)
Sep-30-25 05:01PM	Defensive stocks show deep value as cyclicals run hot, UBS says (Investing.com)
04:57PM	Piper Sandler Reaffirms its Overweight Rating and $115 Price Target on Boston Scientific Corporation (BSX) (Insider Monkey)
Sep-29-25 08:54AM	IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive? (Zacks)
Sep-27-25 11:13AM	3 Healthcare Stocks Using AI to Drive Growth (MarketBeat)
Sep-26-25 08:22AM	Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally? (Zacks)
Sep-25-25 08:24AM	Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It? (Zacks)
Sep-24-25 11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
08:55AM	Is it a Prudent Move to Retain BSX Stock in Your Portfolio for Now? (Zacks)
Sep-22-25 08:00AM	Nvidia Is One Of 10 Stocks Analysts Insist Are Screaming Buys Now (Investor's Business Daily)
Sep-21-25 09:18AM	Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval (Insider Monkey)
Sep-19-25 06:42AM	Market share in US electrophysiology device market (Medical Device Network)
Sep-18-25 12:40PM	Boston Scientific Corporation (BSX) Rated as a 'Buy' at Needham on IVL Market Opportunity (Insider Monkey)
09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
08:42AM	Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio (Zacks)
08:41AM	Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy (Zacks)
Sep-17-25 08:51AM	CAH Strengthens Distribution With New Consumer Health Logistics Hub (Zacks)
08:50AM	GEHC Expands Women's Health Portfolio With AI-Enabled Voluson (Zacks)
Sep-15-25 09:40AM	Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? (Zacks)
09:03AM	Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech (Insider Monkey)
Sep-12-25 07:17AM	Puzzling: Farapulse trial investigator on the devices use beyond recommendations (Medical Device Network)
Sep-11-25 05:18AM	Elutia to divest bioenvelopes business to Boston Scientific for $88m (Medical Device Network)
Sep-10-25 06:00PM	Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know (StockStory)
06:00PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
12:35PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
06:20AM	Boston Scientific inks $88M Elutia deal to challenge Medtronic (MedTech Dive)
Sep-09-25 01:25PM	Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks)
Sep-08-25 12:50PM	Oppenheimer sees stronger growth at Boston Scientific (Investing.com)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Oct 01 04:22 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Sale	98.47	50,000	4,923,327	178,342	Oct 01 04:22 PM
JOSEPH M FITZGERALD	Officer	Oct 01 '25	Proposed Sale	98.47	50,000	4,923,325		Oct 01 04:04 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Sep 03 04:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Sale	105.43	50,000	5,271,416	178,342	Sep 03 04:17 PM
JOSEPH M FITZGERALD	Officer	Sep 02 '25	Proposed Sale	105.43	50,000	5,271,415		Sep 02 04:08 PM
Monson Jonathan	EVP and CFO	Aug 02 '25	Option Exercise	0.00	1,090	0	35,817	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Sale	104.63	50,000	5,231,670	178,342	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Option Exercise	24.81	17,313	429,493	40,913	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Sale	104.63	17,313	1,811,520	23,600	Aug 04 05:43 PM
ARTHUR C BUTCHER	Officer	Aug 01 '25	Proposed Sale	104.63	17,313	1,811,519		Aug 01 04:03 PM
JOSEPH M FITZGERALD	Officer	Aug 01 '25	Proposed Sale	104.63	50,000	5,231,665		Aug 01 04:02 PM
FUJIMORI YOSHIAKI	Director	Jul 29 '25	Sale	106.99	2,901	310,378	2,081	Jul 30 04:06 PM
YOSHIAKI FUJIMORI	Director	Jul 29 '25	Proposed Sale	106.99	2,901	310,378		Jul 29 07:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Sale	106.03	4,000	424,120	18,479	Jul 28 04:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Proposed Sale	107.46	4,000	429,840		Jul 25 01:02 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Jul 02 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Sale	106.97	50,000	5,348,315	178,342	Jul 02 04:09 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01 '25	Option Exercise	0.00	4,036	0	35,403	Jul 02 04:09 PM
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 14 '25	Option Exercise	0.00	16,524	0	1,643,475	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '25	Option Exercise	0.00	4,167	0	183,439	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '25	Option Exercise	0.00	3,960	0	181,078	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 14 '25	Option Exercise	0.00	4,362	0	179,108	Feb 18 05:52 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '25	Option Exercise	0.00	2,834	0	23,550	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '25	Option Exercise	0.00	2,546	0	21,947	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 14 '25	Option Exercise	0.00	3,172	0	20,935	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17 '25	Option Exercise	0.00	1,000	0	51,155	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16 '25	Option Exercise	0.00	1,839	0	51,045	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 14 '25	Option Exercise	0.00	1,850	0	50,101	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 17 '25	Option Exercise	0.00	4,584	0	252,365	Feb 18 05:50 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX

Boston Scientific Corp

Upgrade your FINVIZ experience